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ABSTRACT
Background: The evaluation of patients with lung lesions is challenging. The nature of the lesion
can be determined by pathological evaluation of biopsies. The pulmonologists will be met by
increasing demands with regard to biopsy techniques including ultrasound-guided transthoracic
needle biopsy (US-TTNB).
Objective: The aim of this paper is to present the pulmonologist to a systematic step-by-step
guide for performing US-TTNB and to assess the evidence for this approach.
Method/results: Indications, contraindications and a step-by-step guide for the techniques used
when performing US-TTNB are presented, and major complications and handling of these are
described.
Conclusion: US-TTNB performed by pulmonologists is a safe and feasible procedure.
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Background
The evaluation of patients with lung lesions is challen-
ging. First, the cause of the lesion must be determined,
and second, in the case of malignancy, it is crucial to
determine the correct stage. The advanced computed
tomography (CT) technique has had a major influence
on the detection of suspected malignant lung nodules [1].
Both smaller and increasing numbers of nodules can now
be detected because of improvement in scan resolution
[2,3] and screening for lung cancer with CT is gaining
ground. The correct diagnostic determination of the
pathology of these nodules is imperative since the dis-
tinction between malignant and benign nodules is essen-
tial for treatment planning [4]. Of these reasons, it is
obvious, that we in the future can expect referral of both
a larger number of patients and smaller and smaller
nodules. Additionally, the increased use of markers and
genotyping warrants an increase in the quality and
amount of tissue obtained when performing invasive
procedures. In other words, the pulmonologists will be
met by increasing demands with regard to biopsy techni-
ques including ultrasound-guided lung biopsy.
Centrally located lung lesions and mediastinal lymph
nodes can be biopsied with the use of bronchoscopy or
endosonography. However, these techniques are not fea-
sible or nondiagnostic in a substantial proportion of
patients, especially in the absence of endobronchial
abnormalities or absence of tumor close to trachea or
esophagus. Transcutaneous thoracic biopsy is often use-
ful for peripherally located lung lesions. Transthoracic
biopsy can be performed CT-guided (CT-TTNB), fluoro-
scopy guided or ultrasound guided. Ultrasound-guided
transthoracic needle biopsy (US-TTNB) performed by
pulmonologists is a safe procedure with a very low risk
of complications [5] and is to be preferred especially if the
alternative is diagnostic surgery. The procedure is in
many centers an integrated part of the overall invasive
program performed solely by pulmonologists [5].
The aim of this paper is to present the pulmonolo-
gist to a systematic step-by-step guide for performing
US-TTNB and to assess the evidence for this approach.
Ultrasound-guided biopsy
US-TTNB has an acceptable diagnostic yield [6–10] and is
a cost-effective alternative to CT-guided biopsy [11–15].
The complication rate is generally lower than for CT-
guided biopsies [5,16]. Ultrasound-guided biopsies should
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thus be preferred whenever a lesion can be visualized by
the use of ultrasound. However, a lesion in the central part
of the lungs or peripheral but with no contact to the
visceral pleura, will not be visualized with ultrasound due
to the ultrasoundwave’s reflection in air between the lesion
and the visceral pleura.
In patients with pleural effusion of unknown cause,
the combination of diagnostic thoracentesis and US-
TTNB with pleural biopsy has been demonstrated to be
able to diagnose more than 90% of the patients [17].
The combination of these two modalities should thus
be performed prior to considering thoracoscopy. US-
TTNB can be used to obtain tissue from a variety of
structures such as the chest wall, parietal pleura, lung,
diaphragm and anterior and upper mediastinum.
Additionally, the technique can be used to obtain tissue
from extrathoracic structures such as supraclavicular
and cervical lymph nodes.
Indications
Proper assessment of both indication and contraindi-
cations are important. In some cases, contraindica-
tions may overrule the indication. In other cases,
another invasive procedure may be more appropriate.
Some of the indications for the procedure are as
follows (Figure 1):
● Lung: Peripheral mass or nodule of unknown origin
● Mediastinum: Mass in the anterior mediastinum
or thoracic inlet
● Pleura: Thickening of the parietal pleura or sus-
pected pleural infection
● Chest wall: Tumor or suspected infection
● Lymph nodes: Suspected malignancy, infection or
interstitial lung disease such as sarcoidosis invol-
ving infraclavicular/supraclavicular/axillary or
internal mammary lymph nodes
Contraindications
The risk of complications must always be balanced
against the indication for the procedure, and the pul-
monologist must be fully capable of treating any com-
plication immediately. Relative contraindications
include coagulopathies, severe decompensated heart
failure, unstable angina, symptomatic cardiac arrhyth-
mias, recent myocardial infarction, unstable bronchial
asthma, severe impairment of lung function, respira-
tory failure and severe untreated hypertension. US-
TTNB can be performed on patients with mechanical
ventilation, but the potential clinical impact of obtain-
ing the biopsy should outweigh the increased risk of
pneumothorax and close monitoring is warranted. US-
TTNB can be performed immediately after endoscopy,
for example, as in combined single-day workup and
staging of suspected lung cancer [18].
The patient
Confirmed the patient’s identity, and that the patient has
received relevant information regarding the procedure,
Figure 1. Examples of structures assessable to US-TTNB. (a) A hypoechoic, peripheral lung consolidation (LC) can be seen just
below the pleural line (P). (b) A crescent-shaped thickening of the parietal pleura (P) and a pleural effusion (Eff) can be seen. (c)
Lateral and profound of the sternum (S) a tumor (T) is present in the anterior mediastinum. (d) An enlarged, ill-defined
supraclavicular lymph node (L).
2 I. S. CHRISTIANSEN ET AL.
the risk of complications and informed consent has been
obtained. Review the indication, available imaging, and
make sure to consider any absolute or relative contra-
indications. Ensure that you and your staff are prepared
to handle all potential complications related to this
procedure. Confirm that a pleural drainage system and
emergency medications are in the examination room
ready for use.
Biopsy needles
Generally, a single-needle technique is used for ultra-
sound-guided biopsies. The procedure can be performed
using both aspiration needles as well as core biopsy needles
(Figure 2). Whether an aspiration needle or a core biopsy
needle is chosen for a procedure will depend on the sus-
pected diagnosis (e.g. carcinoma,malignantmesothelioma,
lymphoma, infection), lesion characteristics (e.g. size, pla-
cement, mobility) and patient characteristics (e.g. comor-
bidities, medication). The advantage of the core biopsy is
the amount of obtained tissue whereas the aspiration nee-
dle is less invasive and often easier to use when the lesion is
small and mobile. If doubt exists whether a core biopsy
needle can be used, or the procedure should be limited to
aspiration, a pragmatic approach is to initially perform
aspiration biopsies using aspiration needles. If this can be
easily performed, core biopsies can be performed subse-
quently. Such an approach can also be combined with
rapid on-site evaluation (ROSE) is available [7].
Coated aspiration needles improving ultrasound
visualization are available but these are often expensive.
Generally, standard needles used for other purposes
(e.g. injection, lumbar puncture, Chiba needle) can be
used as less expensive alternatives, reserving the coated
needles for more difficult cases. Abrams needle has
been demonstrated to have a higher diagnostic yield
than conventional cutting needles for the diagnosis of
tuberculous pleuritis. If available, the Abrams needle
should thus be preferred in a setting in which pleural
thickening/pleural effusion due to tuberculosis is more
likely than malignancy [19].
Choice of biopsy technique has an impact on the
optimal needle length for the procedure. If a freehand
technique is used, the length of the needle should
generally be at least the distance of the proposed needle
path from the skin to the middle of the lesion. If
a biopsy guide is used, the length of the biopsy guides
channel should be added to the needle length.
The procedure
US-TTNB should be performed with the patient in
a position allowing for accurate ultrasound visualiza-
tion and also is acceptable for the patient (e.g. sitting,
supine, prone). Equipment for patient monitoring
should be available and used throughout the procedure.
Placement of an intravenous access prior to the proce-
dure is recommended, if complications occur. The
Figure 2. Equipment used for US-TTNB. (a) Examples of biopsy needles: A 21G conventional Chiba needle (1), a 20G coated Chiba
needle (2), an 18G cutting needle (3). (b) Ultrasound transducer with a biopsy guide system. This guide system has three different
adjustable needle angles. (c) Ultrasound transducer with biopsy guide, sterile covering and a 20G coated Chiba needle and syringe.
(d) Ultrasound transducer with biopsy guide, sterile covering and an 18G cutting needle.
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authors do not use intravenous sedation or opioids as
standard care, but it may be necessary in some cases.
Prior to the procedure lung ultrasound is performed
to ensure accurate visualization of the lesion and ade-
quate planning prior to the procedure (e.g. choice of
technique, choice of needle) [14]. Presence or absence of
lung sliding on the anterior chest surface and presence
of pleural effusion should be noted since this informa-
tion is essential when reassessing the patients for the
development of complications following the procedure.
Generally, ultrasound-guided biopsy can be per-
formed using a variety of different techniques. The
three most commonly used techniques are described
in the following.
Ultrasound identification of puncture site
The use of ultrasound may be limited to identifying an
optimal site, angle and depth for performing
a transthoracic biopsy. Once these factors have been
determined, the biopsy is performed ‘blindly’ without
the direct guidance of ultrasound. No studies have
demonstrated whether this technique is inferior to the
techniques using direct ultrasound guidance. Despite
the lack of studies, real-time visualization of the needle
and placement when obtaining the biopsy should be
preferred whenever possible.
Transthoracic ultrasound-guided biopsy using
biopsy guide
When using a biopsy guide, the biopsy can be per-
formed using real-time visualization of the biopsy nee-
dle by the use of ultrasound. Different biopsy guides
systems exist and vary depending on the ultrasound
system used. When using a biopsy guide, an in-plane
(or long axis) technique is used. With this approach,
the needle enters the thoracic wall at the side of the
probe in the guiding system, and it is possible to
visualize the movement of the needle toward the lesion.
When performing lung ultrasound prior to the
biopsy procedure, the optimal biopsy angle is deter-
mined and chosen as the ultrasound preset. The biopsy
handle is attached to the ultrasound transducer. The
angle of the biopsy handle is adjusted so it corresponds
with the biopsy angle chosen as the ultrasound preset
(Figures 2 and 3). Ultrasound gel is applied to the
transducer.
The operator uses sterile gloves. The skin of the
biopsy area is cleansed using an antiseptic fluid. Once
the fluid has dried a sterile dressing can be applied to
ensure that no contamination of the puncture site
occurs during the procedure.
The transducer is then placed in a sterile plastic bag.
The sterile part of the biopsy handle can now be
attached to the transducer. An adapter corresponding
to the needle size (G) is placed in the biopsy handle.
Sterile ultrasound gel is applied to the transducer.
The biopsy site is scanned using the sterile transdu-
cer. Once the optimal biopsy path has been identified
a local anesthetic can be injected using ultrasound
guidance. When injecting the local anesthetic one
should note whether the needle path is still optimal
for the subsequent biopsy procedure. The largest
amount of the local anesthetic should be applied to
the skin and parietal pleura. Once the local anesthetic
has had some time to induce analgesia the biopsy
procedure can be performed. If a core biopsy is per-
formed, a small skin incision is made to facilitate the
needles penetration of the skin. The optimal biopsy site
is once again identified using the transducer. Great care
should be made in order to ensure that no vessels,
nerves, aerated lung or other vital structures are located
in the needle path. Whenever possible, a needle path
Figure 3. Needle guidance on the ultrasound screen. (a) Needle biopsy guide for a given predefined angle can be seen as yellow
dots on the ultrasound screen. The distance between two dots corresponds to 1 cm. A red dot (arrows) is present for every 5 cm. (b)
Ultrasound image of the supraclavicular region. Muscle tissue (M) and a lymph node (L) can be seen. The needle biopsy guide has
been switched on. If the transducer is being held in this position and a needle is inserted, the tip of the needle should enter the
lymph node after having been inserted approximately 5 cm into the guide system as the red dot (1) is located just within the node.
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just above a rib should be chosen in order to minimize
the risk of making a lesion of an intercostal artery.
Once the optimal site has been identified, the trans-
ducer is held fixed in this position. The biopsy needle is
then introduced in the biopsy guide and gently
advanced toward the lesion of interest. When the nee-
dle is advanced one should notice signs of immediate
complications (e.g. pneumothorax). When the needle is
in the lesion, the biopsy can be performed and the
needle gently removed afterward (Figure 4).
Additional biopsies can be performed repeating the
procedure described.
If the biopsy site is not fixed and moves in syn-
chrony with the patients breathing, the procedure has
to be performed in coordination with the patients
breathing. Prior to the biopsy procedure, it is deter-
mined which part of the breathing fazes are optimal
for the biopsy. The patient is instructed on how to
breathe and hold their breath at the ideal time for the
biopsy. The maneuver is briefly trained with the
patient in order to ensure that the patient has under-
stood the instructions. The biopsy procedure is then
performed as described as above, the difference being
when the biopsy needle is introduced. The needle is
advanced until the needle tip is located in the chest
wall a few mm from the parietal pleura. The patient
then holds his/her breath as trained. The biopsy nee-
dle can briefly be advanced and the biopsy performed
with subsequent rapid withdrawal of the needle. The
patient is then allowed to begin breathing again.
When using an aspiration needle, aspiration is per-
formed while the needle tip is within the relevant
structure. There is no evidence regarding the ideal
number of passes within the target lesion when aspir-
ating. If possible we use an approach as is recom-
mended for the endobronchial ultrasound with
10–15 passes. The number of passes has to be reduced
if the lesion is mobile and the patient is only shortly
able to hold his/her breath. Most core biopsy needles
a single pass is sufficient in order to obtain the biopsy.
As mentioned above, ROSE can be used for US-TTNB
[7] where available but is not a requirement.
Transthoracic ultrasound-guided biopsy using
freehand technique
Real-time ultrasound-guided biopsy can also be per-
formed using a freehand technique. When using this
technique, the needle is advanced without the use of
a biopsy guide. The advantage of being a more flexible
choice of angle and needle path when introducing the
needle as well as an option to choose from different
biopsy techniques such as in-plane or out-of-plane
technique. The major disadvantage of the free-hand
technique is that the operator needs to have highly
trained three-dimensional sense of where the needle
is placed and integrate this sense with the information
obtained on the ultrasound image. This is generally
easier when performing biopsies of superficial struc-
tures (e.g. supraclavicular lymph node) and more diffi-
cult with more deeply located structures (e.g. lung
consolidation). When used for transthoracic biopsies,
the technique should generally be reserved for physi-
cians that have more extensive experience in transthor-
acic ultrasound-guided biopsies and who masters the
technique using a biopsy guide.
Supplementary color Doppler can be used to visua-
lize intercostal arteries, other vessels near the lesion,
and in some cases central necrotic areas in the targeted
lesions. However, the movement of the thoracic wall
and lungs during the procedure can be a challenge
when adding Doppler [20].
Handling of the biopsies
It is imperative that the operator knows exactly how to
handle the biopsies with regard to the pathologist´s
requirements for both cytological assessment,
Figure 4. Examples of US-TTNB procedures. (a) US-TTNB of a supraclavicular lymph node (L). A 21G Chiba needle was used (N). (b)
US-TTNB of a small lung tumor (T). The tumor can be seen between the sternum (S) and the pleural line (P). A 18G cutting needle
(N) was used for the procedure.
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immunohistochemistry and mutation analyses. Even the
most perfect biopsy procedure is meaningless if the
samples are not handled correctly.
After the procedure
Once the biopsy procedure has been performed, lung
ultrasound is once again performed to rule-out com-
plications (e.g. pneumothorax, hemothorax, intrapul-
monary bleeding). Ultrasound or chest x-ray is
performed after 1 h.
US pictures of the prebiopsy lung ultrasound exam-
ination, the biopsy procedure and the postbiopsy lung
ultrasound examination should be stored for documen-
tation purposes, and for use in case of difficulties in the
interpretation of the biopsy result or the need for an
additional biopsy procedure.
If the patient within 1 h of the biopsy procedure has
no signs of complications, the patient can be dis-
charged from the outpatient clinic. The patient should
receive instructions on how to act in the case of devel-
oping symptoms of complications within the first 24
h following the biopsy procedure.
Complications
Pneumothorax is one of the most common complica-
tions to transthoracic lung biopsy, sonographic this is
visualized with absence of lung sliding, and confirmed
with the diagnostic sign; lung point. Additionally,
a pneumothorax must be suspected if the lesion sud-
denly is not visual after performing a biopsy.
Pneumothorax after CT-guided transthoracic lung
biopsy occurred in between 18.8 and 25.3% when the
biopsies were performed with a fine needle and core
biopsy, respectively, in a recent meta-analysis [21] but
only in 2.5% (95%CI 0.03–4.6%) of US-TTNB cases [5].
Approximately half of the patients who develop an iatro-
genic pneumothorax, placement of a chest tube is neces-
sary. Lung ultrasound or chest x-ray should be performed
1 h after the procedure as approximately 90% of pneu-
mothoraxes are detected during this time [15,22,23].
The treatment of pneumothorax consists of oxyge-
nation and insertion of a pleural chest tube, for exam-
ple, a 7F tube, followed by aspiration. When defining
a management strategy, the size of the pneumothorax
is less important than the degree of clinical compro-
mise. The differentiation of a ‘large’ from a ‘small’
pneumothorax is the presence of a visible rim of
>2 cm between the lung margin and the chest wall
at the level of the hilum. This is easily measured on
a chest X-ray, but accurate size is best measured by
CT [24–26]. Using lung ultrasound, whether the lung
point is located anteriorly or posteriorly to the mid-
axillary line correlates to a small or large pneu-
mothorax, respectively [27]. Tension pneumothorax
is a medical emergency that should be treated imme-
diately with needle decompression followed by pleural
drainage without waiting for supplemental x-ray or
other investigations.
Bleeding in the lung parenchyma can be seen in
approximately 5–15% of CT-guided lung biopsies.
Lung parenchymal bleeding following transthoracic
biopsies can be diagnosed using lung ultrasound [28]
but no diagnostic accuracy studies have been pub-
lished. It is unknown whether the risk of bleeding
following US-TTNB is the same as with CT-TTNB,
but might be lower since the needle does not pass
normal aerated lung tissue when performing US-
TTNB. Lung parenchymal bleeding can manifest as
hemoptysis, and is only seen in 1–5% of the patients
when the procedure is done CT guided. In
a retrospective multicenter study of US-TTNB proce-
dures, hemoptysis was seen in 0.5% (95%CI 0–1.5%) of
the patients [14].
The treatment of hemoptysis depend on the severity
and may include Tranexamic acid 500–1,000 mg intra-
venously (non-bolus), placement of the patient in
a lateral position with the bleeding lung placed down-
ward giving the nonoperated lung free air access. In the
case of severe bleeding with manifest or threatening
airway, compromise early aggressive airway manage-
ment with endobronchial intubation is imperative since
this allows access to additional airway management.
Bronchoscopy with tamponade and the use of
a balloon catheter, treatment of coagulopathies or coil-
ing may be necessary in severe and refractory cases.
Training of the operator
Only a few studies have explored the educational aspects
of US-TTNB [29], and there is no evidence on how the
most evidence-based or effective educational program
should be composed. Since the procedure is a technical
hands-on procedure, the authors recommend hands-on
training after a theoretic session or sufficient theoretical
knowledge obtained from books or papers. The eye-hand
coordination, and understanding of needle movement is
crucial, no matter which technique is used.
To our knowledge, no phantoms or simulators have
been presented in US-TTNB. Looking at other ultrasound-
guided biopsy training programs, several phantoms have
been created, for example, gelatin blocks with embedded
lesions [30–32]. However, a disadvantage in these home-
made phantoms is, that they are all static, whereas in US-
TTNB the lungs are moving synchronously with the
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patient’s respiration. Further studies are needed to investi-
gate how the most effective training program should be
composed, but until these exist the inexperienced operator
should, if possible train the technique on phantoms, and
always be supervised by an experienced operator until both
operator and supervisor find the level of competence suffi-
cient, and know how to handle complications and critically
situations. Based on our experience we also recommend
that inexperienced operators initially perform US-guided
biopsies of structures which are either technically less diffi-
cult to biopsy or has a low risk of complications (e.g. large
masses, superficial lymph nodes) rather than beginning
with technically challenging cases or more high-risk pro-
cedures (e.g. mediastinal mass, small mobile lung nodules).
Future perspectives for the pulmonologist
It is raised beyond any doubt that the pulmonologist in
the future can expect referral of more patients and
patients with smaller lung lesions, since screening for
lung cancer is gaining ground. Furthermore, there is an
increasing focus on how to provide a fast diagnosis.
US-TTNB in the hands of the pulmonologist is an
important tool in both respects.
An advantage when the procedure is performed by
pulmonologists is that they constantly reassess and
adjust the invasive programme including the indication
and know exactly when diagnosis including immuno-
histochemistry, mutation analyses, microbiology and
staging of the disease is satisfactory. Moreover, they
have close contact with the patient from start to end
of the programme and perform all other invasive pro-
cedures, meaning that the patients only need to see
a single physician. The procedure can be performed
rapidly without the patient having to wait for an avail-
able time-slot in the radiology department.
Ideally, the implementation of US-TTNB performed
by pulmonologists should in the future be based on
training and certification including theoretical courses,
simulator/phantom-based education and clinical train-
ing. The establishment of competence should be based
on an objective and valid assessment of all three before
the patient is exposed to the operator.
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